Sonia Facchin
University of Padua
Internal medicinePathologyAntibodyIntensive care medicineChemistryImmunologyInfliximabInflammatory bowel diseaseSodium butyrateDiseaseCrohn's diseaseTherapeutic drug monitoringUlcerative colitisIn patientPoint of careBiochemistryMedicineCyclin-dependent kinase 2BiologyGastroenterologyCell biologyProtein kinase Ac-Raf
53Publications
11H-index
364Citations
Publications 53
Newest
#1Daria Maniero (UNIPD: University of Padua)H-Index: 2
#2Greta Lorenzon (UNIPD: University of Padua)H-Index: 8
Last. Ilaria Marsilio (UNIPD: University of Padua)H-Index: 7
view all 0 authors...
Source
#1Michele Berlanda (UNIPD: University of Padua)H-Index: 5
Last. Ilaria PatuzziH-Index: 7
view all 10 authors...
Chronic enteropathies (CE) are gastrointestinal diseases that afflict about one in five dogs in Europe. Conventional therapeutic approaches include dietary intervention, pharmacological treatment and probiotic supplements. The patient response can be highly variable and the interventions are often not resolutive. Moreover, the therapeutic strategy is usually planned (and gradually corrected) based on the patient’s response to empirical treatment, with few indirect gut health indicators useful to...
Source
Anti-drug antibodies can interfere with the activity of anti-tumor necrosis factor (TNF) agents by increasing drug clearance via direct neutralization. The presence of anti-drug antibodies is clini...
Source
#1Flavia Merigo (University of Verona)H-Index: 24
#2Alessandro Brandolese (University of Verona)H-Index: 3
Last. Andrea Sbarbati (University of Verona)H-Index: 59
view all 9 authors...
The expression of leptin and leptin receptor (Ob-R) has been partially elucidated in colon of patients with inflammatory bowel diseases (IBDs), even though leptin is involved in angiogenesis and inflammation. We previously reported overexpression of GLUT5 fructose transporter, in aberrant clusters of lymphatic vessels in lamina propria of IBD and controls. Here, we examine leptin and Ob-R expression in the same biopsies. Specimens were obtained from patients with ulcerative colitis (UC), Crohn's...
Source
#1Davide Massimi (UNIPD: University of Padua)H-Index: 3
#2Brigida Barberio (UNIPD: University of Padua)H-Index: 7
Last. Renata D'Incà (UNIPD: University of Padua)H-Index: 60
view all 0 authors...
Background:Current literature still lacks studies evaluating the effectiveness and safety of switching from Infliximab originator to SB2 biosimilar in Inflammatory Bowel Diseases (IBDs). We aimed t...
Source
#1Sonia FacchinH-Index: 11
#2Andrea BudaH-Index: 26
Last. Edoardo SavarinoH-Index: 60
view all 3 authors...
Source
Source
#1Brigida Barberio (UNIPD: University of Padua)H-Index: 7
#2Davide Massimi (UNIPD: University of Padua)H-Index: 3
Last. Anna Maria Cattelan (UNIPD: University of Padua)H-Index: 31
view all 8 authors...
1 CitationsSource
#1Brigida Barberio (UNIPD: University of Padua)H-Index: 7
#2Sonia Facchin (UNIPD: University of Padua)H-Index: 11
Last. Edoardo Savarino (UNIPD: University of Padua)H-Index: 60
view all 12 authors...
Background:Faecal microbiota transplantation (FMT) is a reasonable therapeutic option for the treatment of Clostridioides difficile infection (CDI) recurrent and refractory (RCDI) to therapy, but l...
1 CitationsSource
#1Sonia FacchinH-Index: 11
#2Nicola Vitulo (University of Verona)H-Index: 27
Last. Edoardo SavarinoH-Index: 60
view all 12 authors...
BACKGROUND Butyrate has shown anti-inflammatory and regenerative properties, providing symptomatic relief when orally supplemented in patients suffering from various colonic diseases. We investigated the effect of a colonic-delivery formulation of butyrate on the fecal microbiota of patients with inflammatory bowel diseases (IBDs). METHODS In this double-blind, placebo-controlled, pilot study, 49 IBD patients (n = 19 Crohn's disease, CD and n = 30 ulcerative colitis, UC) were randomized to oral ...
4 CitationsSource